PRF Technologies Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
2.040
-0.250 (-10.92%)
At close: Apr 28, 2026, 4:00 PM EDT
2.200
+0.160 (7.84%)
After-hours: Apr 28, 2026, 7:49 PM EDT
Company Description
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel.
It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations.
The company was formerly known as PainReform Ltd. and change its name to PRF Technologies Ltd. in January 2026.
The company was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
PRF Technologies Ltd.
| Country | Israel |
| Founded | 2007 |
| IPO Date | Sep 1, 2020 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Efraim Cohen-Arazi |
Contact Details
Address: 65 Yigal Alon St. Tel Aviv-Yafo, 6744316 Israel | |
| Phone | 972 3 7177050 |
| Website | painreform.com |
Stock Details
| Ticker Symbol | PRFX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $8.00 |
| CIK Code | 0001801834 |
| CUSIP Number | M77798201 |
| ISIN Number | IL0011651580 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Efraim Cohen-Arazi | Interim Chief Executive Officer and Director |
| Dr. Ehud Geller Ph.D. | Executive Chairman |
| Eyal Broder | Chief Financial Officer |
| Dr. Sigal Aviel eMBA, Ph.D. | Chief Operating Officer |
| Dr. Stephen A. Cooper D.M.D Ph.D. | Executive Vice President of Development |
| Rita Keynan M.Sc. | Vice President of Pharmaceutical Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 28, 2026 | 6-K | Report of foreign issuer |
| Mar 27, 2026 | 6-K | Report of foreign issuer |
| Mar 26, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Mar 17, 2026 | 6-K | Report of foreign issuer |
| Mar 3, 2026 | 6-K | Report of foreign issuer |
| Feb 18, 2026 | 6-K | Report of foreign issuer |
| Feb 11, 2026 | 6-K | Report of foreign issuer |
| Feb 3, 2026 | 6-K | Report of foreign issuer |
| Jan 20, 2026 | 6-K | Report of foreign issuer |
| Jan 15, 2026 | 6-K | Report of foreign issuer |